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Peripheral neuropathy is a common and severe dose-limiting side eﬀect of the chemotherapy agent, bortezomib, in multiple
myeloma patients. Treatment with narcotics, antidepressants, and anticonvulsants has limited response and potential signiﬁcant
side eﬀects. Acupuncture has been reported to be eﬀective in treating diabetic neuropathy and chemo-induced peripheral
neuropathy. There has not been report on the eﬀect of acupuncture in treating bortezomib-induced peripheral neuropathy
speciﬁcally. Here, we report a successful case of using acupuncture to relieve bortezomib-induced peripheral neuropathy
symptoms.
1.Introduction
Peripheral neuropathy in patients with multiple myeloma
occurs as both disease- and treatment-related complication
in the relapsed and newly diagnosed setting. Bortezomib is a
novel agent in treating multiple myeloma [1]. Bortezomib-
induced peripheral neuropathy (BIPN) is one of the most
common and severe toxicities of bortezomib resulting in
dose reduction or drug discontinuation [2]. The incidence
of BIPN varies from 37% for grade 3 to >80% for all grades
[2]. Small percentage (∼6%) patients can develop painful
peripheral neuropathy that usually occurs acutely and takes
al o n gt i m et or e s o l v e[ 3]. BIPN usually occurs within the
ﬁrst 5 cycles of bortezomib and may resolve between 3 to
48 months after the discontinuation of the drug [2]. Major
risk factors for BIPN are cumulative dose of bortezomib
and pre-existing peripheral neuropathy from other causes
such as diabetes or multiple myeloma. Only 31% (11/35) of
patients experiencing grade 3 BIPN had complete symptoms
resolution after discontinuing bortezomib [4]. Prospective
clinical trial with nerve conduction study suggests that
BIPN is a length-dependent, sensory, axonal, large-ﬁber
polyneuropathy [5]. Little is known about the mechanism of
BIPN. Animal studies suggest that BIPN may be the result
of mild to moderate pathological changes in Schwann cells
and myelin, axonal degeneration, and dorsal root ganglia
neuron changes [6] .T h ed o r s a lr o o tg a n g l i a ln e u r o n a lc e l l
body changes may result from proteasome inhibitor such
as bortezomib, which induces chromatolysis of dorsal root
ganglial neurons and causes cytoplasmic accumulation of
eosinophilicmaterial[6].Neurophysiologicalstudiesshowed
that bortezomib induced changes in all three major primary
aﬀerent ﬁbers: Aβ,A δ,a n dC[ 7].
The clinical characteristics of BIPN are consistent with
dysfunction of sensory nerves causing spontaneous pain,
paresthesia (tingling, numbness), hyperalgesia (increase sen-
sitivity to painful stimuli), allodynia (hypersensitivity to
non-painful stimuli), and decreased physical activity [8].
Patientsmayexperienceneuropathicpaininthestockingand
glove distribution with an average pain score being 7.8 out
of 10 [7]. They may have distal sensory loss, with the loss
in lower extremities being worse than the upper extremities.
They may have decreased deep tendon reﬂexes and changes
in proprioception that aﬀects daily activities. In addition, up
to 10% of patients with BIPN experience grade 1–3 motor
neuropathy [2] .T h et r e a t m e n tf o rB I P Nh a sb e e nl i m i t e d2 Pain Research and Treatment
to symptom management with narcotics, antidepressants,
anticonvulsants, and vitamins [2]. Studies suggest that such
analgesic regimens usually only produce modest pain relief
and are associated with side eﬀects such as sedation, dry
mouth, and constipation [2, 3, 7]. Therefore, more eﬀective
and less toxic treatments for BIPN are needed.
The eﬃcacy of acupuncture for treating diabetic periph-
eral neuropathy and HIV-related peripheral neuropathy has
been suggested in a number of clinical trials [9–16]. There
have been a number of clinical trials showing the eﬀect
of acupuncture in reducing neuropathic pain in cancer
patients[17,18].Oneclinicaltrialshowedtheeﬀectivenessof
auricular acupuncture in treating cancer treatment induced
neuropathy [18]. A case series suggested potential eﬃcacy of
body acupuncture in treating patients with chemotherapy-
induced peripheral neuropathy (CIPN) [19]. To date, there
has not been any clinical trial to study the eﬀect of acupunc-
tureinalleviatingBIPNsymptoms[8].Here,wereportasuc-
cessfulcase of using acupunctureto relieve BIPN symptoms.
2.CaseReport
A 48-year-old African-American man with multiple my-
eloma presented with multiple bony lesions. Past medical
history was signiﬁcant for hypertension and hyperlipidemia.
He was a bus driver. He received induction therapy with
bortezomib 1.3mg/m2 IV on days 1, 4, 8, and 11, cyclophos-
phamide 300mg/m2 IV on days 1 and 8, and dexamethasone
40mg PO on days of bortezomib. Cycles were repeated every
21 days. After three cycles, he achieved partial remission
and underwent autologous peripheral blood stem cell
transplantation. He then achieved complete remission. After
he ﬁnished the third cycle of bortezomib, he developed
BIPN with tingling, numbness, and burning pain of feet
below the ankle despite being oﬀ bortezomib therapy and
relatively low cumulative dose of the drug. His symptoms
worsened over the next four months to the point that he
was not able to stand or walk normally because of the severe
pain. He was started on neurontin in escalating doses but
was unable to tolerate doses over 1200mg daily due to side
eﬀects, mostly dizziness. He was given morphine sulphate
(MS) contin 15mg PO twice daily with oxycodone 5mg PO
every 4 to 6 hours for breakthrough pain with no signiﬁcant
improvement. Pregabalin 75mg PO twice daily was added
without signiﬁcant pain relief. His BIPN symptoms persisted
with pain, tingling, numbness, and poor quality of life from
the pain and pain medications. In addition, he was unable to
drivebecauseofpainandsideeﬀectsofhispainmedications.
He was referred for acupuncture treatment.
During the patient’s initial visit he had signiﬁcant pares-
thesia/in bilateral lower extremities. No autonomic symp-
tomswerereported.Hisself-reportedoverallpainscorewas8
out of 10 on a 11-point visual analog scale (VAS). Neurolog-
ical exam showed reduced sensation to light touch, pin, and
vibration in distal part of his feet and absent ankle reﬂexes
bilaterally. Muscle strength was ﬁve out of 5 throughout with
limited lower extremity movement because of severe pain.
The patient was treated with an acupuncture protocol,
whichincludesbilateralearpoints:shenmen,pointzero,two
Shen men
Point zero
LI11
SJ5
LI4
ST40
Rt. ear
Ba Feng
Figure 1: Acupuncture protocol to treat bortezomib-induced
peripheral neuropathy.
additional auricular acupuncture point where electrodermal
signal was detected [18], and bilateral body acupuncture
points:LI4,SJ5,LI11,ST40,andasetofextraordinarypoints,
Ba Feng (Figure 1). For auricular points, the electrodermal
signal was detected through a hand-held auricular acupoint
ﬁnder (the Pointer-Excell II) where a buzzing sound went
oﬀ when the electrodermal signal is detected. He was treated
once per week for six treatments. He noted that the initial 2
acupuncture sessions gave him pain relief for only a few
hours. But the subsequent acupuncture treatments gave
him progressively longer pain relief. At the end of his six
acupuncture treatments, his self-reported overall pain score
went down from 8 out of 10 to 2 out of 10 on VAS. His
use of breakthrough pain medication (oxycodone) decreased
from 20 to 30mg daily to 5 to 10mg daily. He no longer had
diﬃculty walking and standing. He continued acupuncture
every other week for four treatments, then once every
three weeks for two treatments, and ﬁnished with once per
month for two treatments. At the end of his 14 acupuncture
treatments, he stopped taking MS contin and Oxycodone
and was able to go back to work to drive buses. He has
been followed every three months and had no recurrent
symptoms at last followup, 1 year after the initiation of his
symptoms. Throughout his 14 acupuncture treatments, no
adverse events related to acupuncture were noted.
3. Discussion
This is the ﬁrst case report on the use of acupuncture
in treating multiple myeloma patients with BIPN. Our
report suggests that acupuncture is a treatment option for
patients experiencing BIPN. Fourteen acupuncture treat-
ments helped the patient to have signiﬁcant less neuropathic
pain, reduced requirement for narcotics, and improved
function with minimal side eﬀects.
The acupuncture protocol was developed from our
clinical experience and prior chemo-induced peripheralPain Research and Treatment 3
neuropathy acupuncture research [18, 19]. One randomized,
blinded clinical trial showed the eﬀectiveness of auricular
acupuncture in treating cancer therapy induced neuropathy
[18]. The patients were randomized into one of three arms.
One arm received real auricular acupuncture embedded at
real ear acupuncture points, which is deﬁned as points where
the electrodermal signal is being detected. The other two
arms were sham control arms: one received real auricular
acupuncture at the placebo points and one received sham
acupuncture through auricular seeds at the placebo points
[18]. All patients received two courses of real or sham
auricular acupuncture in two consecutive months. The
needles were left in place until they fell out or were removed
at a followup appointment. Their pain intensity measured by
VAS at the end of the second month was used to measure the
treatment eﬃcacy. This study showed that in the group that
receivedrealacupuncture,painintensitydecreasedby36%at
the end of 2 months when compared with baseline, whereas
it only decreased by 2% in the placebo groups (P<. 0001)
[18]. Moreover, a case series suggested potential eﬃcacy of
body acupuncture in treating patients with chemotherapy-
induced peripheral neuropathy (CIPN) [19]. Five patients
with greater than world health organization grade II CIPN
were treated with 6 weekly acupuncture treatments followed
by 4 weeks of rest and 6 additional weekly acupuncture
treatments. All patients but one ﬁnished all 12 acupuncture
treatments. All ﬁve patients reported improvement in
pain, tingling, and numbness. Pain scores decreased from
6–9/10 to 2–3/10 after acupuncture treatments. All patients
had reduced analgesic medication intake. Four out of ﬁve
patients reported persistent symptoms relief at the 6 month
followup [19].
We observed similar eﬀect in our case report to those
aforementioned reports, which is that patient with CIPN
responded to acupuncturetreatments. Ourcasesuggeststhat
acupuncture may be eﬀective in relieving BIPN symptoms.
Although studies have not been able to fully explain the
mechanism of acupuncture, it has been proposed that
acupuncture works through its eﬀect on neurotransmitters
and neurohormones [20–23]. Animal research suggests that
acupunctureaccomplishesitsanesthesiaeﬀectbystimulating
nerves in the muscle, which then relay the signal to the
spinal cord, midbrain, and hypothalamus-pituitary system,
which then lead to the release of neurotransmitters and
hormones, that is, endorphins and enkephalins [24–26].
Other mechanisms such as activation of descending pain
inhibiting pathways, deactivation of the limbic system, corti-
calcerebralvasodilationcausingreleaseofneuropeptide,and
inhibition of the release of inﬂammatory factors have also
been suggested to explain the eﬀect of acupuncture analgesia
[27–31]. Recent study also showed that electroacupuncture
alleviates bone cancer pain by suppressing spinal expression
of interleukin-1β in glia cells that are involved in the spinal
transmission and processing of noxious inputs from the
peripheral sites and facilitates pain [32]. It is perceivable that
acupuncture reduces BIPN symptoms by suppressing activ-
ities of glial cell and stimulating neurohormonal pathways,
which increases endorphins release and reduces proinﬂam-
matory cytokines. Further study needs to be conducted to
explore the role of acupuncture in helping patients suﬀering
from BIPN and its mechanisms of action.
Our case report is limited in a couple of ways. First,
the patient’s relief of peripheral neuropathy symptoms may
be due to a spontaneous remission rather than the eﬀect
of acupuncture. However, based on our clinical experience,
o n c eB I P Nb e c o m e ss os e v e r et h a ti ti n t e r f e r e sw i t hd a i l y
activities, it rarely resolves by itself, and even so, it usually
takes a long time (months to years) to do so. Second,
the clinical improvement in this patient was primarily
documented by subjective end point, the VAS score. Changes
in objective end points such as detailed neurological exam
and nerve conduction study will help understand how
acupuncture worked in reducing BIPN. This case report is
the beginning of our endeavor to investigate the role of
acupuncture in relieving BIPN. We plan to incorporate more
objective measurements such as nerve conduction study into
future studies on this topic.
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